tiprankstipranks
Trending News
More News >
Mayne Pharma Group Ltd. (AU:MYX)
OTHER OTC:MYX
Australian Market

Mayne Pharma Group (MYX) Income Statement

Compare
48 Followers

Mayne Pharma Group Income Statement

Last quarter (Q4 2025), Mayne Pharma Group's total revenue was AU$195.04M, an increase of 136.64% from the same quarter last year. In Q4, Mayne Pharma Group's net income was AU$-68.29M. See Mayne Pharma Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 408.10MAU$ 388.15MAU$ 183.59MAU$ 157.15MAU$ 400.78M
Gross Profit
AU$ 247.27MAU$ 218.53MAU$ 26.84MAU$ 23.75MAU$ 127.02M
Operating Expenses
AU$ 270.87MAU$ 357.59MAU$ 213.28MAU$ 145.62MAU$ 125.65M
Depreciation and Amortization
AU$ 64.11MAU$ 68.46MAU$ 65.44MAU$ 55.18MAU$ 68.19M
EBITDA
AU$ 42.08MAU$ -116.93MAU$ -193.80MAU$ -78.88MAU$ -182.40M
Operating Income
AU$ -23.59MAU$ -139.06MAU$ -186.44MAU$ -121.88MAU$ 1.36M
Other Income/Expenses
AU$ -59.70MAU$ -51.02MAU$ -83.25MAU$ -23.71MAU$ -265.25M
Pretax Income
AU$ -83.30MAU$ -190.09MAU$ -269.70MAU$ -145.59MAU$ -263.89M
Net Income
AU$ -93.84MAU$ -174.23MAU$ 117.25MAU$ -281.29MAU$ -208.42M
Per Share Metrics
Basic EPS
AU$ -1.14AU$ -2.19AU$ -3.89AU$ -3.46AU$ -2.57
Diluted EPS
AU$ -1.14AU$ -2.19AU$ -3.89AU$ -3.46AU$ -2.57
Weighted Average Shares Outstanding
82.31M 79.62M 81.25M 81.25M 81.25M
Weighted Average Shares Outstanding (Diluted)
79.14M 79.62M 81.25M 81.25M 81.25M
Currency in AUD

Mayne Pharma Group Earnings and Revenue History